Active Substance & Generic Molecule Directory

Clopidogrel in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Clopidogrel registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

13
Registered Brands
Availability in Malaysia:13 Prescription (MAL-A)
Showing 13 of 13 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL11115010AZAntiPlatt 75mg Tablet USP (Clopidogrel 75mg USP)97.875mg 0Prescription (MAL-A)UNIMED SDN. BHD.Compare →
MAL07090937AZApo-Clopidogrel 75mg Film-Coated Tablets98.0 mg 0Prescription (MAL-A)PHARMAFORTE (MALAYSIA) SDN. BHD.Compare →
MAL08010791AZCERUVIN TABLETS 75 mg97.88 mg 0Prescription (MAL-A)RANBAXY (MALAYSIA) SDN. BHD.Compare →
MAL12055034AZClopistad (Clopidogrel Film-Coated Tablet 75mg)97.86mg 0Prescription (MAL-A)STADPHARM SDN. BHD.Compare →
MAL06061677AZClopivid tablet 75 mg97.90 mg 1 tabletPrescription (MAL-A)HOVID BERHADCompare →
MAL12055018ACZClovix 75mg Tablet97.875mg 255mgPrescription (MAL-A)Abio Marketing Sdn BhdCompare →
MAL10043690AZDEPLATT TABLET USP 75MG97.875 mgPrescription (MAL-A)LABORATORIES TORRENT (MALAYSIA) SDN. BHD.Compare →
MAL13025037ACZGridokline Tablets 75mg97.875mg 0Prescription (MAL-A)THE ZYFAS MEDICAL CO.,Compare →
MAL09122044AZKogrel 75mg film coated tablets97.875 mgPrescription (MAL-A)SANDOZ PRODUCTS MALAYSIA SDN. BHD.Compare →
MAL20102092AZPlacta Tablet 75mg97.87 mgPrescription (MAL-A)DCH AURIGA (MALAYSIA) SDN. BHD.Compare →
MAL10100020AZPlavix Tablet 300mg391.5 mg 0Prescription (MAL-A)SANOFI-AVENTIS (MALAYSIA) SDN. BHD.Compare →
MAL19992344AZPLAVIX TABLET 75MG75mgPrescription (MAL-A)SANOFI-AVENTIS (MALAYSIA) SDN. BHD.Compare →
MAL11060018AZTROKEN TABLET 75MG97.857 mg 0Prescription (MAL-A)THE ZYFAS MEDICAL CO.,Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.